Interpace Biosciences Inc (IDXG) earnings · P/E 1.8, rev $18.2M
Interpace Biosciences Inc (IDXG) is a diagnostics & research company listed on OTCQX.
This IDXG earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IDXG revenue for 2026-06-30 was $18.2M. Net income was $879.0K. IDXG currently screens at market cap $43.5M and trailing P/E 1.8.
When the next IDXG 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for IDXG. We will not invent a beat or miss.
Not investment advice. Full IDXG research stays on the stock page; the tape stays on the quote page.
Not investment advice.